Benjamin Crouch, DO
Physical Medicine & Rehabilitation · Provo, UTNPI 1336302546
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,196 of the $5,824 with a category attached, or 72.0%. 26 manufacturers reported payments, led by Relievant Medsystems, Inc. at 39.5% of the total. Reporting peaked in 2023 at $1,804 and has fallen 51.8% since, to $870 in 2025. Among physical medicine & rehabilitation clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $34.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$2K
- Boston Scientific$1K
- Medtronic$758
- Stryker$528
- Amgen$191
- Saluda Medical Americas, Inc.$148
- plus $813 from 20 others
What the payments were for
- Travel & lodging$1,62828%
- Food & beverage$4,19672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 25 | $2,298 |
| Boston Scientific | 36 | $1,087 |
| Medtronic(2 entities) | 44 | $758 |
| Stryker | 10 | $528 |
| Amgen | 9 | $191 |
| Saluda Medical Americas, Inc. | 2 | $148 |
| Radius Health, Inc. | 6 | $106 |
| Collegium Pharmaceutical, Inc. | 5 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $85 |
| Averitas Pharma Inc. | 3 | $79 |
| Vertex | 4 | $72 |
| Abbott | 4 | $71 |
| Orthofix Medical, Inc. | 2 | $69 |
| Painteq LLC | 1 | $40 |
| Globus Medical | 1 | $26 |
| Pfizer | 2 | $24 |
| Arteriocyte Medical Systems, Inc. | 1 | $22 |
| GRT US Holding, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Acell, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Curonix LLC | 1 | $15 |
| SPR Therapeutics, Inc | 1 | $14 |
| Si-bone, Inc. | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $13 |
| KCI USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$5,972
- SPINEJACK$354
- SPECTRA WAVEWRITER$159
- INTELLIS ADAPTIVESTIM$122
- Evoke$116
How this compares
$5,824 in reported general payments places this provider in the 90th percentile of 117 physical medicine & rehabilitation providers in Utah.
See all physical medicine & rehabilitation providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 15 | $11,619 |
| BelbucaBuprenorphine Hcl | 12 | $9,727 |
| Xtampza ErOxycodone Myristate | 13 | $8,951 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 233 | $8,555 |
| MovantikNaloxegol Oxalate | 14 | $5,679 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 200 | $5,194 |
| Fentanyl | 40 | $4,094 |
| Tramadol Hcl ErTramadol Hcl | 22 | $2,124 |
| Gabapentin | 124 | $2,033 |
| Oxycodone Hcl | 93 | $1,468 |
| Pregabalin | 81 | $1,267 |
| Lidocaine | 11 | $1,204 |
| Methocarbamol | 67 | $906 |
| Diclofenac Sodium | 59 | $841 |
| Tramadol Hcl | 108 | $820 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $87 | $18,67825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 117 physical medicine & rehabilitation providers in Utah.
Other physical medicine & rehabilitation in Provo
- Jonathan BenfieldProvo$3K
- Kellen HiltonProvo$2K
- Scott AdelmanPark City$143K
- Judith GoochSlc$43K
- Colby BealSt George$25K
- Stephen AndersonBountiful$11K
- Timothy GrangeSalt Lake City$11K
- Matthew IrvinSt George$9K
- Steven EdgleySalt Lake City$8K
- Ammon HillsLogan$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.